Navigation Links
Overuse of Opioids, Barbiturates Boosts Chronic Migraine Risk
Date:4/17/2008

Self-treating headaches with these drugs doubles chance of having chronic episodes

THURSDAY, April 17 (HealthDay News) -- Taking barbiturates and opioids such as codeine and oxycodone too often for migraines could double the chances of having chronic migraines a year later, new research says.

The study, expected to be presented Thursday at the American Academy of Neurology annual meeting in Chicago, found no increased risk for chronic migraine among people using other common treatments such as triptans or nonsteroidal anti-inflammatory drugs (NSAIDs), including aspirin, ibuprofen and naproxen.

Having migraines on 15 or more days a month is considered a chronic condition.

Those studied had been diagnosed in 2005 with episodic migraines (fewer than 15 days of headache per month) and asked about the types of medications they used that year. Those who took medicines containing barbiturates or opioids for only eight days a month in 2005 were twice as likely to develop chronic migraine a year later as those who didn't take such drugs.

"People who use drugs that contain barbiturates and opioids, if only for a total of seven to eight days a month, appear to significantly increase their risk of migraine progression," study author Marcelo Bigal, of Albert Einstein College of Medicine in New York City, said in a prepared statement. "Strict limits for these types of drugs should be enforced among people with migraine as a way of preventing their migraines from becoming more frequent and more painful."

More information

The U.S. National Library of Medicine has more about migraines.



-- Kevin McKeever



SOURCE: American Academy of Neurology, news release, April 17, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Prolonged Fasting Boosts Risk of Rare Stroke
2. Omega-3 intake during last months of pregnancy boosts an infant’s cognitive and motor development
3. Antipsychotic Drug Boosts Risk of Heart Disease, Diabetes
4. Green Tea Boosts Antibiotics for Superbugs
5. Abdominal Fat Boosts Dementia Risk
6. Artery Plaque Boosts Hispanics Odds for Stroke
7. Stopping a receptor called nogo boosts the synapses
8. New Method Boosts Cardiac Arrest Survival
9. Smoking Boosts Bleeding Stroke Risk in Those With High Blood Pressure
10. NetMotion Wireless Boosts Mobile Productivity for Visiting Nurse Service of New York
11. Fixing Poor Vision Boosts Preschoolers Test Scores
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... innovative inhaled drugs, announced today that it was added ... reconstituted its comprehensive set of U.S. and global ... is an important milestone for Pulmatrix," said Chief Executive ... awareness of our progress in developing drugs for crucial ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
Breaking Medicine Technology: